darunavir accord 150 mg tabletki powlekane
accord healthcare polska sp. z o.o. - darunavirum - tabletki powlekane - 150 mg
darunavir accord 300 mg tabletki powlekane
accord healthcare polska sp. z o.o. - darunavirum - tabletki powlekane - 300 mg
darunavir accord 400 mg tabletki powlekane
accord healthcare polska sp. z o.o. - darunavirum - tabletki powlekane - 400 mg
darunavir accord 600 mg tabletki powlekane
accord healthcare polska sp. z o.o. - darunavirum - tabletki powlekane - 600 mg
darunavir accord 800 mg tabletki powlekane
accord healthcare polska sp. z o.o. - darunavirum - tabletki powlekane - 800 mg
darunavir glenmark 600 mg tabletki powlekane
glenmark pharmaceuticals s.r.o. - darunavirum - tabletki powlekane - 600 mg
darunavir aurovitas 800 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - darunavirum - tabletki powlekane - 800 mg
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - białaczka, szpikowe - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.